source
- U.S. Treasury Considers New Screening Rules for Investments in Chinese BiotechTreasury Department officials are reviewing possible measures to screen U.S. capital flowing into Chinese biotechnology firms, according to multiple sources familiar with the discussions. The revi…
- Biogen to acquire RayThera in up to $1 billion deal for immunology pipelineBiogen announced it will acquire RayThera, a startup founded in 2023, in a deal valued at up to $1 billion. The acquisition gives Biogen access to RayThera’s immunology pipeline, which includes th…